Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, has announced that Manuel Llobet, Chief Executive Officer, Nick Wykeman, Chief Financial Officer, and Alan Bullimore, Head of Business Innovation of Allergy Therapeutics, will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place from 9-10 March, 2021. The presentation will be made available on-demand for participants from 9 March, 2021.
A replay of the presentation will be made available under the ‘Investors’ section on Allergy Therapeutics’ website at www.allergytherapeutics.com/investors/results-reports-and-presentations/
